R. Scott Struthers

2.6k total citations
78 papers, 2.0k citations indexed

About

R. Scott Struthers is a scholar working on Molecular Biology, Reproductive Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, R. Scott Struthers has authored 78 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Biology, 31 papers in Reproductive Medicine and 20 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in R. Scott Struthers's work include Receptor Mechanisms and Signaling (29 papers), Hypothalamic control of reproductive hormones (28 papers) and Chemical Synthesis and Analysis (19 papers). R. Scott Struthers is often cited by papers focused on Receptor Mechanisms and Signaling (29 papers), Hypothalamic control of reproductive hormones (28 papers) and Chemical Synthesis and Analysis (19 papers). R. Scott Struthers collaborates with scholars based in United States, Brazil and United Kingdom. R. Scott Struthers's co-authors include Greg J. Reinhart, Wylie Vale, Yunfei Zhu, Trudy A. Kohout, Chen Chen, Stephen J. Perry, Paul E. Sawchenko, Marc Montminy, Carlos Arias and John Saunders and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

R. Scott Struthers

74 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
R. Scott Struthers United States	25	933	629	368	368	307	78	2.0k
Greg J. Reinhart United States	17	878 0.9×	277 0.4×	145 0.4×	207 0.6×	89 0.3×	29	1.3k
Adalı́ Pecci Argentina	22	689 0.7×	99 0.2×	482 1.3×	108 0.3×	197 0.6×	61	1.5k
Ritwik Burai United States	14	602 0.6×	71 0.1×	690 1.9×	113 0.3×	257 0.8×	19	1.4k
Keishi Matsumoto Japan	24	724 0.8×	379 0.6×	599 1.6×	52 0.1×	538 1.8×	101	1.7k
Christopher J. Caunt United Kingdom	25	1.5k 1.7×	329 0.5×	303 0.8×	42 0.1×	173 0.6×	40	2.3k
J M Allen United Kingdom	7	402 0.4×	252 0.4×	204 0.6×	168 0.5×	82 0.3×	8	1.1k
Phuong Nguyen United States	22	1.4k 1.5×	63 0.1×	1.2k 3.3×	90 0.2×	455 1.5×	53	2.3k
A. Bailly France	19	710 0.8×	125 0.2×	797 2.2×	30 0.1×	259 0.8×	26	1.4k
M. Manin France	19	476 0.5×	93 0.1×	215 0.6×	403 1.1×	235 0.8×	40	1.4k
Fred Schaufele United States	31	1.6k 1.7×	72 0.1×	832 2.3×	41 0.1×	610 2.0×	52	2.4k

Countries citing papers authored by R. Scott Struthers

Since Specialization

Citations

This map shows the geographic impact of R. Scott Struthers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Scott Struthers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Scott Struthers more than expected).

Fields of papers citing papers by R. Scott Struthers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Scott Struthers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Scott Struthers. The network helps show where R. Scott Struthers may publish in the future.

Co-authorship network of co-authors of R. Scott Struthers

This figure shows the co-authorship network connecting the top 25 collaborators of R. Scott Struthers. A scholar is included among the top collaborators of R. Scott Struthers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Scott Struthers. R. Scott Struthers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Biller, Beverly M. K., Christian J. Strasburger, Martin Bidlingmaier, et al.. (2025). OR12-07 Disease Control in Patients With Acromegaly Switching From Injected Somatostatin Receptor Ligands to Once-Daily Oral Paltusotine: Interim Results of the PATHFNDR-1 Open-Label Extension. Journal of the Endocrine Society. 9(Supplement_1).

Madan, Ajay, et al.. (2025). Oral paltusotine, a nonpeptide selective somatostatin receptor 2 agonist: Mass balance, absolute bioavailability and metabolism in healthy participants. British Journal of Clinical Pharmacology. 91(7). 2070–2079.

Gadelha, Mônica R., Атанаска Еленкова, César Luiz Boguszewski, et al.. (2025). MON-069 Once-daily Oral Paltusotine In The Treatment Of Patients With Biochemically Uncontrolled Acromegaly: Interim Results Of The PATHFNDR-2 Open-label Extension. Journal of the Endocrine Society. 9(Supplement_1).

Gadelha, Mônica R., Christian J. Strasburger, Martin Bidlingmaier, et al.. (2024). Acromegaly Disease Control Maintained After Switching From Injected Somatostatin Receptor Ligands to Oral Paltusotine. The Journal of Clinical Endocrinology & Metabolism. 110(1). 228–237. 12 indexed citations

Auchus, Richard J., Peter Trainer, Kathryn Jean Lucas, et al.. (2024). 12537 Once Daily Oral Atumelnant (CRN04894) Induces Rapid And Profound Reductions Of Androstenedione And 17-Hydroxyprogesterone In Participants With Classical Congenital Adrenal Hyperplasia: Initial Results From A 12-Week, Phase 2, Open-Label Study. Journal of the Endocrine Society. 8(Supplement_1). 3 indexed citations

Gadelha, Mônica R., Murray B. Gordon, Mirjana Doknić, et al.. (2022). ACROBAT Edge: Safety and Efficacy of Switching Injected SRLs to Oral Paltusotine in Patients With Acromegaly. The Journal of Clinical Endocrinology & Metabolism. 108(5). e148–e159. 19 indexed citations

Kim, Sun Hee, Sangdon Han, Elizabeth Rico-Bautista, et al.. (2022). Discovery of 4-(3-aminopyrrolidinyl)-3-aryl-5-(benzimidazol-2-yl)-pyridines as potent and selective SST5 agonists for the treatment of congenital hyperinsulinism. Bioorganic & Medicinal Chemistry Letters. 71. 128807–128807. 2 indexed citations

Chen, Zhiyong, Ana Karin Kusnetzow, Julie Nguyen, et al.. (2020). Discovery of substituted 3H-pyrido[2,3-d]pyrimidin-4-ones as potent, biased, and orally bioavailable sst2 agonist. Bioorganic & Medicinal Chemistry Letters. 30(21). 127496–127496. 3 indexed citations

Han, Sangdon, Ana Karin Kusnetzow, Julie Nguyen, et al.. (2020). Discovery of nonpeptide 3,4-dihydroquinazoline-4-carboxamides as potent and selective sst2 agonists. Bioorganic & Medicinal Chemistry Letters. 30(17). 127391–127391. 5 indexed citations

10.

Struthers, R. Scott. (2012). Gonadotropin‐Releasing Hormone Targeting for Gonadotroph Ablation: An Approach to Non‐surgical Sterilization. Reproduction in Domestic Animals. 47(s4). 233–238. 7 indexed citations

11.

Guo, Zhiqiang, Yongsheng Chen, Tao Hu, et al.. (2008). 5-Aryluracils as potent GnRH antagonists—Characterization of atropisomers. Bioorganic & Medicinal Chemistry Letters. 18(11). 3344–3349. 9 indexed citations

12.

Mi, Chen, Zhiqiang Guo, Marion Lanier, et al.. (2007). Identification of 2-(4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-3-yl)-ethylamine derivatives as novel GnRH receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 17(14). 3845–3850. 9 indexed citations

13.

Ott, Thomas, et al.. (2006). The N-terminal domain of CCL21 reconstitutes high affinity binding, G protein activation, and chemotactic activity, to the C-terminal domain of CCL19. Biochemical and Biophysical Research Communications. 348(3). 1089–1093. 18 indexed citations

14.

Struthers, R. Scott, Susan K. Sullivan, Greg J. Reinhart, et al.. (2006). Pharmacological Characterization of a Novel Nonpeptide Antagonist of the Human Gonadotropin-Releasing Hormone Receptor, NBI-42902. Endocrinology. 148(2). 857–867. 29 indexed citations

15.

Perry, Stephen J., Trudy A. Kohout, Sam R.J. Hoare, et al.. (2005). Distinct Conformations of the Corticotropin Releasing Factor Type 1 Receptor Adopted following Agonist and Antagonist Binding Are Differentially Regulated. Journal of Biological Chemistry. 280(12). 11560–11568. 51 indexed citations

16.

Guo, Zhiqiang, Dongpei Wu, Yunfei Zhu, et al.. (2005). Structure–activity relationships of 1,3,5-triazine-2,4,6-triones as human gonadotropin-releasing hormone receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 15(16). 3685–3690. 8 indexed citations

17.

Rowbottom, Martin W., Fábio C. Tucci, Patrick J. Connors, et al.. (2004). Synthesis and structure–activity relationships of uracil derived human GnRH receptor antagonists: (R)-3-[2-(2-amino)phenethyl]-1-(2,6-difluorobenzyl)-6-methyluracils containing a substituted thiophene or thiazole at C-5. Bioorganic & Medicinal Chemistry Letters. 14(19). 4967–4973. 13 indexed citations

18.

Ott, Thomas, Anil Pahuja, Sarah A. Nickolls, David G. Alleva, & R. Scott Struthers. (2004). Identification of CC Chemokine Receptor 7 Residues Important for Receptor Activation. Journal of Biological Chemistry. 279(41). 42383–42392. 21 indexed citations

19.

Guo, Zhiqiang, Yongsheng Chen, Dongpei Wu, et al.. (2003). Synthesis and structure–Activity relationships of thieno[2,3-d]pyrimidine-2,4-dione derivatives as potent GnRH receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 13(20). 3617–3622. 20 indexed citations

20.

Millar, Robert P., et al.. (2000). Progress towards the development of non-peptide orally-active gonadotropin-releasing hormone (GnRH) antagonists: therapeutic implications. British Medical Bulletin. 56(3). 761–772. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact